.svg){kind=icon}
SmartSolve® for Compliance
AI‑enabled quality and regulatory compliance you can trust.
White Paper
Speed Can Mislead: Why Velocity Matters Most in Global Regulatory Affairs
Jun 08, 2026
This white paper explains why focusing on velocity rather than just speed leads to better regulatory outcomes in life sciences. It highlights how patient-centric, context-driven AI helps improve submission quality, reduce risk, and accelerate approvals in global regulatory affairs. It also demonstrates how aligning clinical evidence, data, and regulatory expectations creates more consistent and successful submissions.
Related solutions
SmartSolve® eQMS for Lifesciences
Outdated compliance practices aren't viable amid evolving market and regulatory changes. IQVIA’s award-winning, end-to-end quality management system streamlines the product value chain, accelerates market entry, safeguards companies and patient safety, and meets complex regulatory demands.
SmartSolve® RIM
SmartSolve® RIM manages regulatory submissions, product registrations, and health authority interactions.